Location History:
- Osaka, JP (2014 - 2015)
- Tokushima, JP (2010 - 2018)
Company Filing History:
11 out of 846 
1 out of 167 Years Active: 2010-2018
Title: Innovator Spotlight: Takahiro Tomoyasu
Introduction
Takahiro Tomoyasu, a prominent inventor based in Tokushima, Japan, has made remarkable contributions to the field of pharmaceuticals through his innovative research and patented inventions. With a total of 11 patents to his name, Tomoyasu has demonstrated a commitment to advancing therapeutic methods and creating effective pharmaceutical solutions.
Latest Patents
Among his latest patents is a groundbreaking development involving N,N-substituted 3-aminopyrrolidine compounds, designed to serve as monoamine reuptake inhibitors. This invention presents a unique pyrrolidine compound identified by General Formula (1) or its salts, where the components R and R can independently be either a phenyl group or a pyridyl group. These groups have the potential for one or more substituents, including halogen atoms and lower alkyl groups that may also be substituted by halogen atoms. The significance of this patent lies in its capability to produce pharmaceutical preparations that exhibit a wider therapeutic spectrum, ensuring substantial therapeutic effects even after short-term administration.
Career Highlights
Takahiro Tomoyasu has been associated with esteemed companies such as Otsuka Pharmaceutical Company, Limited and Otsuka Chemical Co., Ltd. His work in these organizations has given him a robust platform to pursue innovative research in the pharmaceutical sector.
Collaborations
Throughout his career, Tomoyasu has collaborated with notable colleagues such as Yasuhiro Menjo and Shin Miyamura. These partnerships have no doubt facilitated the exchange of ideas, contributing to the successful development of his patents and innovations.
Conclusion
Takahiro Tomoyasu stands out as a distinguished inventor who is shaping the future of pharmaceuticals through his innovative work. His contributions, especially in the realm of monoamine reuptake inhibitors, highlight the importance of creativity and collaboration in advancing medicinal science. As he continues to add to his portfolio of patents, the impact of his inventions will likely resonate within the industry for years to come.